Loading…

Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays

We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 1999-05, Vol.19 (6), p.883-891
Main Authors: Sadick, Michael D, Intintoli, Anthony, Quarmby, Valerie, McCoy, April, Canova-Davis, Eleanor, Ling, Victor
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63
cites cdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63
container_end_page 891
container_issue 6
container_start_page 883
container_title Journal of pharmaceutical and biomedical analysis
container_volume 19
creator Sadick, Michael D
Intintoli, Anthony
Quarmby, Valerie
McCoy, April
Canova-Davis, Eleanor
Ling, Victor
description We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.
doi_str_mv 10.1016/S0731-7085(98)00144-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69441800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708598001447</els_id><sourcerecordid>17252482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</originalsourceid><addsrcrecordid>eNqF0U1rFDEYwPEgFrtWP4KSg0h7mJrM5NWLlKK2tCD4AuIlZJInEJlNxiS70G_vbHfR3noIufzyJPyD0CtKzimh4t03IgfaSaL4qVZnhFDGOvkEraiSQ9cL9vMpWv0jx-h5rb8JIZxq9gwdUyK04pyt0K-bmGwFXMDB3HLB1rW4tS3mhE9vrr9enL3HFhc7R49tWpZzm2IbYDs1KGmBW8AtY0i-m3NMDY8x21rtXX2BjoKdKrw87Cfox6eP3y-vutsvn68vL247x3raOj4EqYnqwWqhuPd-7H0AGIUMzkmuA1dyBLuwEJQDpygnAcbAaZBk8GI4QW_3c-eS_2ygNrOO1cE02QR5U43QjFFFyKOQyp73TPUL5HvoSq61QDBziWtb7gwlZlff3Nc3u7RGK3Nf38jl3OvDBZtxDf7BqX3uBbw5AFudnUKxycX630khlN7N-bBnsGTbRiimugjJgY_LPzXjc3zkJX8Bh2Wh0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17252482</pqid></control><display><type>article</type><title>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Sadick, Michael D ; Intintoli, Anthony ; Quarmby, Valerie ; McCoy, April ; Canova-Davis, Eleanor ; Ling, Victor</creator><creatorcontrib>Sadick, Michael D ; Intintoli, Anthony ; Quarmby, Valerie ; McCoy, April ; Canova-Davis, Eleanor ; Ling, Victor</creatorcontrib><description>We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(98)00144-7</identifier><identifier>PMID: 10698554</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Biological and medical sciences ; Biological Assay - methods ; Enzyme Activation ; Enzyme-Linked Immunosorbent Assay - methods ; General pharmacology ; Humans ; Insulin-Like Growth Factor I - analysis ; Kinase receptor activation (KIRA) ; Ligand bioactivity ; Medical sciences ; Pharmacology. Drug treatments ; Phosphorylation ; Rapid bioassay ; Receptor phosphorylation ; Receptor Protein-Tyrosine Kinases - analysis ; Receptor Protein-Tyrosine Kinases - metabolism ; Receptor, trkA - analysis ; Tumor Cells, Cultured ; Viral Envelope Proteins - analysis</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 1999-05, Vol.19 (6), p.883-891</ispartof><rights>1999 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</citedby><cites>FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1766897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10698554$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sadick, Michael D</creatorcontrib><creatorcontrib>Intintoli, Anthony</creatorcontrib><creatorcontrib>Quarmby, Valerie</creatorcontrib><creatorcontrib>McCoy, April</creatorcontrib><creatorcontrib>Canova-Davis, Eleanor</creatorcontrib><creatorcontrib>Ling, Victor</creatorcontrib><title>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>Biological Assay - methods</subject><subject>Enzyme Activation</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor I - analysis</subject><subject>Kinase receptor activation (KIRA)</subject><subject>Ligand bioactivity</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorylation</subject><subject>Rapid bioassay</subject><subject>Receptor phosphorylation</subject><subject>Receptor Protein-Tyrosine Kinases - analysis</subject><subject>Receptor Protein-Tyrosine Kinases - metabolism</subject><subject>Receptor, trkA - analysis</subject><subject>Tumor Cells, Cultured</subject><subject>Viral Envelope Proteins - analysis</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqF0U1rFDEYwPEgFrtWP4KSg0h7mJrM5NWLlKK2tCD4AuIlZJInEJlNxiS70G_vbHfR3noIufzyJPyD0CtKzimh4t03IgfaSaL4qVZnhFDGOvkEraiSQ9cL9vMpWv0jx-h5rb8JIZxq9gwdUyK04pyt0K-bmGwFXMDB3HLB1rW4tS3mhE9vrr9enL3HFhc7R49tWpZzm2IbYDs1KGmBW8AtY0i-m3NMDY8x21rtXX2BjoKdKrw87Cfox6eP3y-vutsvn68vL247x3raOj4EqYnqwWqhuPd-7H0AGIUMzkmuA1dyBLuwEJQDpygnAcbAaZBk8GI4QW_3c-eS_2ygNrOO1cE02QR5U43QjFFFyKOQyp73TPUL5HvoSq61QDBziWtb7gwlZlff3Nc3u7RGK3Nf38jl3OvDBZtxDf7BqX3uBbw5AFudnUKxycX630khlN7N-bBnsGTbRiimugjJgY_LPzXjc3zkJX8Bh2Wh0A</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>Sadick, Michael D</creator><creator>Intintoli, Anthony</creator><creator>Quarmby, Valerie</creator><creator>McCoy, April</creator><creator>Canova-Davis, Eleanor</creator><creator>Ling, Victor</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</title><author>Sadick, Michael D ; Intintoli, Anthony ; Quarmby, Valerie ; McCoy, April ; Canova-Davis, Eleanor ; Ling, Victor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>Biological Assay - methods</topic><topic>Enzyme Activation</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor I - analysis</topic><topic>Kinase receptor activation (KIRA)</topic><topic>Ligand bioactivity</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorylation</topic><topic>Rapid bioassay</topic><topic>Receptor phosphorylation</topic><topic>Receptor Protein-Tyrosine Kinases - analysis</topic><topic>Receptor Protein-Tyrosine Kinases - metabolism</topic><topic>Receptor, trkA - analysis</topic><topic>Tumor Cells, Cultured</topic><topic>Viral Envelope Proteins - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadick, Michael D</creatorcontrib><creatorcontrib>Intintoli, Anthony</creatorcontrib><creatorcontrib>Quarmby, Valerie</creatorcontrib><creatorcontrib>McCoy, April</creatorcontrib><creatorcontrib>Canova-Davis, Eleanor</creatorcontrib><creatorcontrib>Ling, Victor</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadick, Michael D</au><au>Intintoli, Anthony</au><au>Quarmby, Valerie</au><au>McCoy, April</au><au>Canova-Davis, Eleanor</au><au>Ling, Victor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>19</volume><issue>6</issue><spage>883</spage><epage>891</epage><pages>883-891</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>10698554</pmid><doi>10.1016/S0731-7085(98)00144-7</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 1999-05, Vol.19 (6), p.883-891
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_69441800
source ScienceDirect Freedom Collection 2022-2024
subjects Analysis
Biological and medical sciences
Biological Assay - methods
Enzyme Activation
Enzyme-Linked Immunosorbent Assay - methods
General pharmacology
Humans
Insulin-Like Growth Factor I - analysis
Kinase receptor activation (KIRA)
Ligand bioactivity
Medical sciences
Pharmacology. Drug treatments
Phosphorylation
Rapid bioassay
Receptor phosphorylation
Receptor Protein-Tyrosine Kinases - analysis
Receptor Protein-Tyrosine Kinases - metabolism
Receptor, trkA - analysis
Tumor Cells, Cultured
Viral Envelope Proteins - analysis
title Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A43%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinase%20receptor%20activation%20(KIRA):%20a%20rapid%20and%20accurate%20alternative%20to%20end-point%20bioassays&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Sadick,%20Michael%20D&rft.date=1999-05-01&rft.volume=19&rft.issue=6&rft.spage=883&rft.epage=891&rft.pages=883-891&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(98)00144-7&rft_dat=%3Cproquest_cross%3E17252482%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17252482&rft_id=info:pmid/10698554&rfr_iscdi=true